Related Articles
EFFECTS OF SUBCUTANEOUS RECOMBINANT IL-2 ON HUMORAL IMMUNITY IN ADVANCED CANCER-PATIENTS
Subcutaneous recombinant interleukin-2 plus alpha interferon and vinblastine in metastatic renal cell carcinoma
COMBINED INTERLEUKIN-2 AND OKT3 THERAPY IN THE TREATMENT OF METASTATIC MELANOMA
Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19
EVALUATION OF PHAGOCYTIC-ACTIVITY IN NEOPLASTIC PATIENTS TREATED WITH SUBCUTANEOUS RECOMBINANT IL-2